This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Cephalon, Inc. (NASDAQ: CEPH) (referred to as "Cephalon" or the “Company”) by Teva Pharmaceutical Industries Ltd. (“Teva”) in a cash transaction with a total enterprise value of approximately $6.8 billion.
Under the terms of the merger agreement, Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash.